Skip to main content
OpenTrials
Completed

NCT Number: NCT04493268

HYPONATREMIA IN COVID-19 PATIENTS

SYSTEMIC INFLAMMATION HAS BEEN ASSOCIATED WITH SEVERE COVID-19. HYPONATREMIA CAN RESULT FROM INFLAMMATION DUE TO NON-OSMOTIC STIMULI FOR VASOPRESSIN PRODUCTION. IN THIS PROSPECTIVE COHORT STUDY WE ANALIZED DATA FROM PATIENTS WITH COVID-19 AND THE ASOCIATION WITH HYPONATREMIA AND CLINICAL OUTCOMES.

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • PATIENTS WITH SARS-CoV-2 INFECTION CONFIRMED BY PCR OF NASOPHARYNGEAL SWABS.

Exclusion criteria

-

Treatment and study plan

Primary outcomes

  1. MORTALITY

    Time frame: 30 DAYS

    HYPONATREMIA AND MORTALITY

Secondary outcomes

  1. ICU HOSPITALIZATION

    Time frame: 30 DAYS

    HYPONATREMIA AND ICU HOSPITALIZATION

Sponsors and collaborators

Lead sponsor

Hospital Nacional Profesor Alejandro Posadas

Other

Registry information

Official study title

HYPONATREMIA AND INFLAMMATION AND CLINICAL OUTCOMES IN HOSPITALIZED COVID-19 PATIENTS

Important dates

Study start
2020
Primary completion
2020
Study completion
2020
First posted
Jul 30, 2020
Registry last updated
Jul 30, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.